We are Sorry, This Page doesn't Exist

NEW YORK, March 16, 2020 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. ("Mustang") (NASDAQ:MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene.....»»

Welcome to the first edition of Psyched, a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry. read more.....»»

Just under a year after its debut on public markets, a Durham gene therapy company says it is positioned – scientifically and financially – for a strong 2020......»»

~ Patient Dosing Nearly Completed in Phase III HOPE-B Trial of Etranacogene Dezaparvovecin Hemophilia B ~ ~ First Patient Procedure in Phase I/II Clinical Trial of AMT-130 in Hun.....»»

Passage Bio, a gene therapy developer seeking to commercialize technology developed by Penn Medicine researchers, raised $216 million through an initial public stock offering Friday. The Philadelphia company sold 12 million shares at $18 per shar.....»»

LogicBio Therapeutics had hoped to begin testing what could be the first gene-targeting treatment designed specifically for infants and children, but FDA qualms have put a moratorium on those plans. Regulators placed a clinical hold this week on a .....»»

Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced new interim clinical data from th.....»»

The gene therapy company is expected to introduce hemophilia drug that is projected to generate revenue of $1.2 billion by 2024Related Stocks: BMRN, GS, RHHBY, SGMO,.....»»

Shares of Applied Genetic Technologies Corp (NASDAQ: AGTC) are tumbling Thursday despite the company reporting encouraging results from an Phase 1/2 study. 0 read more.....»»

Neurotrope announced the results of its latest confirmatory clinical trial......»»

Shares of thinly-traded gene therapy company Genprex Inc (NASDAQ: GNPX) are soaring on more than 50 times their average volume Tuesday. 0 read more.....»»

Krystal Biotech announced Tuesday that it had named Jennifer Chien to the newly created position of chief commercial officer, effective Monday. Chien joins the Pittsburgh-based gene therapy company after serving as vice president, head of geneti.....»»

Shares of Applied Genetic Technologies Corp. soared 60% on heavy volume in premarket trading on Thursday after the biotechnology company reported positive results from a Phase 1/2 trial for its investigational gene therapy for retinitis pigmentosa, a dis.....»»

The company is taking innovative approaches to treat severe brain diseases......»»

If you’d invested $1,000 in BioLife Solutions a decade ago, you would have made nearly $19,000 by doing nothing more than holding onto the stock through Thursday. The Bothell-based cell and gene therapy company by far had the best gain on inves.....»»

A gene therapy invented at Nationwide Children's Hospital just landed a licensing deal worth as much as $2.8 billion for a Boston biotech, and now the company's Columbus office will play a big role in getting the treatment to the market. Sarepta Th.....»»

Shares of Allergan gained 0.5% after the Food and Drug Administration approved Ubrelvy, its migraine treatment. In two late-stage clinical trials, more patients who were taking the experimental therapy reported the pain ending within t.....»»

Shares of genetic therapy company Homology Medicines Inc (NASDAQ: FIXX) were moving to the downside Wednesday. 0 read more.....»»

The U.S.-based company is holding the trial in Colombia......»»

Judy Chou will go from a multinational company that made everything from aspirin to hemophilia A treatments to a smaller company with multiple drugs in clinical trials......»»